This course features 20 sessions designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Topics include: Cardiology, Diabetes, Endocrinology, Gastroenterology, Hepatology, Infectious Disease, Nephrology, Psychiatry, Pulmonology, Rheumatology, and Women’s Health.
This activity will provide the attendee with the latest up-to-date information and state-of-the-art management strategies using oral antiplatelet drugs for Acute Coronary Syndrome patients based on the 2013 ACC/AHA Guidelines.
The ACC/AHA guidelines has 9 recommendations for hypertension. Dr. Charles Sneiderman reviews the new guidelines published in 2014 by the National Institutes of Health eighth Joint National Committee (JNC8).
Heart failure is an economic loss with almost thirty-two billion dollars spent annually to cover the expenses incurred due to this disease including medications for treatment, provision of health care, and work days lost. With careful attention to evidence based guidelines for care and comprehensive, holistic, and collaborative efforts made by providers, patients and payers, this challenging disease can be tackled both effectively and efficiently.
Renal Medication Dosing. One of the most difficult propositions for practitioners is the adjustment of medications when dosing for Chronic Kidney Disease (CKD). This article serves to update the non-nephrology practitioner on the practical dosing of medications for the CKD patient in 2012.
Chronic Kidney Disease: A New Paradigm. Since diabetes and hypertension are diseases of aging, the increase in the number of CKD patients will continue for the foreseeable future. The Government’s Healthy People 2020 goals acknowledges the burden of CKD and encourages practitioners to aggressively treat these patients to attempt to lower the morbidity and mortality caused by CKD. This article highlights outcome-driven treatments that can assist the practitioner in accomplishing that goal.